American International Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-803
| Closed | -$46K | – | 3257 |
|
|
2022
Q1 | $46K | Sell |
803
-56
| -7% | -$3.21K | ﹤0.01% | 2874 |
|
|
2021
Q4 | $102K | Sell |
859
-26
| -3% | -$3.09K | ﹤0.01% | 2708 |
|
|
2021
Q3 | $176K | Sell |
885
-21
| -2% | -$4.18K | ﹤0.01% | 2498 |
|
|
2021
Q2 | $158 | Sell |
906
-146
| -14% | -$25 | ﹤0.01% | 2652 |
|
|
2021
Q1 | $208 | Buy |
1,052
+2
| +0.2% | – | ﹤0.01% | 2346 |
|
|
2020
Q4 | $207 | Buy |
1,050
+46
| +5% | +$9 | ﹤0.01% | 2272 |
|
|
2020
Q3 | $178K | Sell |
1,004
-23
| -2% | -$4.08K | ﹤0.01% | 2206 |
|
|
2020
Q2 | $238K | Buy |
1,027
+407
| +66% | +$94.3K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $72K | Sell |
620
-35
| -5% | -$4.07K | ﹤0.01% | 2503 |
|
|
2019
Q4 | $125K | Sell |
655
-6
| -0.9% | -$1.15K | ﹤0.01% | 2495 |
|
|
2019
Q3 | $127K | Sell |
661
-4
| -0.6% | -$769 | ﹤0.01% | 2462 |
|
|
2019
Q2 | $114K | Buy |
665
+178
| +37% | +$30.5K | ﹤0.01% | 2605 |
|
|
2019
Q1 | $98K | Buy |
487
+53
| +12% | +$10.7K | ﹤0.01% | 2631 |
|
|
2018
Q4 | $81K | Buy |
434
+1
| +0.2% | +$187 | ﹤0.01% | 2699 |
|
|
2018
Q3 | $104K | Buy |
433
+8
| +2% | +$1.92K | ﹤0.01% | 2819 |
|
|
2018
Q2 | $112K | Buy |
+425
| New | +$112K | ﹤0.01% | 2720 |
|